Industry Outlook
The cell surface markers market is set to reach US$ 33,712.7 Mn by 2026 from US$ 16,586.7 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Technological advancements in the production of monoclonal antibodies and manufacturing of cell specific antibodies for disease diagnosis and prognosis are the major factors to drive the cell surface markers market.
Pharmaceutical companies are engaged in the production of staining dyes and reagents which are employed in determining specific cytological protocols propel the cell surface markers market growth. The limitations associated with cell surface markers market is the frequent occurrence of false positive results and suffer tremendous competition from new generation sequencing technique for drug discovery and disease diagnosis.
"Increasing demand of targeted drug delivery and stem cell research will have a positive impact on flow cytometers market"
Reagents and kits are currently dominating the cell surface markers market by type segment on account of its application in determining microscopic cellular functions. They are widely used in understanding the cell signaling pathways and pharmacodynamic activities taking place at the G-protein coupled receptors etc. The reagents and kits are used to decipher cellular activities by the antigen-antibody reaction such as agglutination reaction, precipitation reaction, complement fixation, enzyme linked immunosorbent assay (ELISA) and immunofluorescence. Flow cytometers widely employ the cell surface markers to identify the cell population of hematopoietic stem cells such as CD 19, 20, 4 and CD34+ in the biological sample to understand the cell migration in diabetes and cardiovascular disease.
"Increasing use of cell surface markers in developing monoclonal antibodies to treat chronic diseases will boost drug discovery segment"
Cell surface markers are proteins that are expressed on the cell surface, which are helpful in identifying the lineage and differentiation stage. In the present scenario cell surface markers find huge demand in drug discovery and development as they help in analyzing epigenetic modification, gene regulation and genotyping. Rising prevalence of chronic diseases and increasing public health awareness has resulted in the burgeoning requirement of cell surface markers in disease diagnosis.
"Development of immunoassays for the quantification of biological samples to drive the diagnostic laboratories market"
In the last two decades there has been tremendous technological advancement in the development of immunoassays for quantification of biological samples. Cell surface markers are widely employed by pathologist in performing clinical and forensic investigation which has a positive impact on the market growth of diagnostic laboratories. Cell surface markers are utilized by aspiring researchers in academia for understanding the disease etiology of chronic idiopathic diseases, and to develop novel medicines for their treatment.
"Increasing number of diagnostic laboratories to drive the cell surface markers market in Asia Pacific"
Rising incidence of chronic diseases and existence of well-developed healthcare infrastructure are responsible for the dominance of North America in cell surface markers market. Presence of market leaders such as Abbott Laboratories, Inc., and F.Hoffman La-Roche AG., determine the cell surface markers market in Europe. Asia Pacific will register impressive growth throughout the forecast period owing to the increasing number of diagnostic laboratories and enhanced government funding in establishing new research and academia centers.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
Quantitative analysis was performed to determine the existing market trends prevalent in cell surface markers market. Competitive landscape is deciphered to get a gist of the technological advancement taking place in cell surface markers market. In the latest news development segment the importance has been given to highlight the major merger & acquisitions and other growth strategies adopted by major players. Different types of reagent and kits used in drug discovery and disease diagnosis are covered in the product portfolio segment. The major players in the cell surface markers market are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., F.Hoffman La-Roche AG, Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation and Thermo Fischer Scientific, Inc.
Key questions answered in this report
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global CSM Market Portraiture
2.2. Global CSM Market, by Type, 2017 (US$ Mn)
2.3. Global CSM Market, by Application, 2017 (US$ Mn)
2.4. Global CSM Market, by End Users, 2017 (US$ Mn)
2.5. Global CSM Market, by Geography, 2017 (US$ Mn)
Chapter 3. Cell Surface Markers (CSM) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CSM Market, by Key Players, 2017
Chapter 4. Global Cell Surface Markers (CSM) Market, by Type
4.1. Overview
4.2. Flow Cytometers
4.3. Hematology Analyzers
4.4. Reagents and Kits
Chapter 5. Global Cell Surface Markers (CSM) Market, by Application
5.1. Overview
5.2. Drug Discovery
5.3. Disease Diagnosis
Chapter 6. Global Cell Surface Markers (CSM) Market, by End Users
6.1. Overview
6.2. Diagnostic Laboratories
6.3. Research and Academia
Chapter 7. Global Cell Surface Markers (CSM) Market, by Geography
7.1. Overview
7.2. North America CSM Market Analysis, 2016 – 2026
7.2.1. North America CSM Market, by Type, 2016 – 2026 (US$ Mn)
7.2.2. North America CSM Market, by Application, 2016 – 2026 (US$ Mn)
7.2.3. North America CSM Market, by End Users, 2016 – 2026 (US$ Mn)
7.2.4. North America CSM Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe CSM Market Analysis, 2016 – 2026
7.3.1. Europe CSM Market, by Type, 2016 – 2026 (US$ Mn)
7.3.2. Europe CSM Market, by Application, 2016 – 2026 (US$ Mn)
7.3.3. Europe CSM Market, by End Users, 2016 – 2026 (US$ Mn)
7.3.4. Europe CSM Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Cell Surface Markers Drugs Market Analysis, 2016 – 2026
7.4.1. Asia Pacific CSM Market, by Type, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific CSM Market, by Application, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific CSM Market, by End Users, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific CSM Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America CSM Market Analysis, 2016 – 2026
7.5.1. Latin America CSM Market, by Type, 2016 – 2026 (US$ Mn)
7.5.2. Latin America CSM Market, by Application, 2016 – 2026 (US$ Mn)
7.5.3. Latin America CSM Market, by End Users, 2016 – 2026 (US$ Mn)
7.5.4. Latin America CSM Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa CSM Market Analysis, 2016 – 2026
7.6.1. MEA CSM Market, by Type, 2016 – 2026 (US$ Mn)
7.6.2. MEA CSM Market, by Application, 2016 – 2026 (US$ Mn)
7.6.3. MEA CSM Market, by End Users, 2016 – 2026 (US$ Mn)
7.6.4. MEA CSM Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Beckman Coulter, Inc.
8.3. BD Biosciences
8.4. Bio-Rad Laboratories, Inc.
8.5. F.Hoffman La-Roche AG
8.6. Grifols SA
8.7. Immucor, Inc.
8.8. Janssen Diagnostics, Inc.
8.9. Nihon Kohden Corporation
8.10. Thermo Fischer Scientific, Inc.
* CSM - Cell Surface Markers
TABLE 1 Global Cell Surface Markers (CSM) Market Portraiture
TABLE 2 Global CSM Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global CSM Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global CSM Market , by End Users, 2016 – 2026 (US$ Mn)
TABLE 5 Global CSM Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America CSM Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America CSM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 8 North America CSM Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 9 North America CSM Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe CSM Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 11 Europe CSM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 12 Europe CSM Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 13 Europe CSM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific CSM Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific CSM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific CSM Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific CSM Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America CSM Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America CSM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America CSM Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America CSM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa CSM Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa CSM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa CSM Market, by End Users, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa CSM Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 26 Abbott Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Beckman Coulter, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 BD Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 F.Hoffman La-Roche AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Grifols SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Immucor, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Janssen Diagnostics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Nihon Kohden Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Thermo Fischer Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments
FIG. 1 Cell Surface Markers (CSM) Market: Research Methodology
FIG. 2 CSM Market Segmentation
FIG. 3 Global CSM Market, by Type, 2017 (US$ Mn)
FIG. 4 Global CSM Market, by Application, 2017 (US$ Mn)
FIG. 5 Global CSM Market, by End Users, 2017 (US$ Mn)
FIG. 6 Global CSM Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: by Geography, 2017
FIG. 8 Competitive Analysis: Global CSM Market, by Key Players, 2017
FIG. 9 Global Flow Cytometers Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 10 Global Hematology Analyzers Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 11 Global Reagents & Kits Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 12 Global Drug Discovery Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 13 Global Disease Diagnosis Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 14 Global Diagnostic Laboratories Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 15 Global Research & Academia Market for Cell Surface Markers, 2016 – 2026 (US$ Mn)
FIG. 16 U.S. CSM Market, 2016 – 2026 (US$ Mn)
FIG. 17 Canada CSM Market, 2016 – 2026 (US$ Mn)
FIG. 18 U.K. CSM Market, 2016 – 2026 (US$ Mn)
FIG. 19 Germany CSM Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Europe CSM Market, 2016 – 2026 (US$ Mn)
FIG. 21 China CSM Market, 2016 – 2026 (US$ Mn)
FIG. 22 Japan CSM Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Asia Pacific CSM Market, 2016 – 2026 (US$ Mn)
FIG. 24 Brazil CSM Market, 2016 – 2026 (US$ Mn)
FIG. 25 Mexico CSM Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of Latin America CSM Market, 2016 – 2026 (US$ Mn)
FIG. 27 GCC CSM Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Middle East and Africa CSM Market, 2016 – 2026 (US$ Mn)